Plus Therapeutics Inc (PSTV)
1.18
-0.02
(-1.67%)
USD |
NASDAQ |
Nov 22, 16:00
1.20
+0.02
(+1.69%)
After-Hours: 20:00
Plus Therapeutics Cash from Operations (Quarterly): -3.68M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -3.68M |
June 30, 2024 | -1.15M |
March 31, 2024 | -4.513M |
December 31, 2023 | -1.881M |
September 30, 2023 | -2.399M |
June 30, 2023 | -2.778M |
March 31, 2023 | -5.793M |
December 31, 2022 | -2.234M |
September 30, 2022 | -4.222M |
June 30, 2022 | -2.64M |
March 31, 2022 | -3.876M |
December 31, 2021 | -2.624M |
September 30, 2021 | -2.251M |
June 30, 2021 | -2.399M |
March 31, 2021 | -3.006M |
December 31, 2020 | -3.224M |
September 30, 2020 | -2.299M |
June 30, 2020 | -1.409M |
March 31, 2020 | -1.502M |
December 31, 2019 | 1.036M |
September 30, 2019 | -2.522M |
June 30, 2019 | -1.15M |
March 31, 2019 | -3.27M |
December 31, 2018 | -2.488M |
September 30, 2018 | -2.647M |
Date | Value |
---|---|
June 30, 2018 | -2.721M |
March 31, 2018 | -4.119M |
December 31, 2017 | -4.224M |
September 30, 2017 | -4.049M |
June 30, 2017 | -5.028M |
March 31, 2017 | -4.827M |
December 31, 2016 | -4.161M |
September 30, 2016 | -4.637M |
June 30, 2016 | -5.677M |
March 31, 2016 | -5.058M |
December 31, 2015 | -4.522M |
September 30, 2015 | -6.158M |
June 30, 2015 | -4.758M |
March 31, 2015 | -5.03M |
December 31, 2014 | -4.956M |
September 30, 2014 | -7.237M |
June 30, 2014 | -9.175M |
March 31, 2014 | -8.962M |
December 31, 2013 | -9.499M |
September 30, 2013 | -8.05M |
June 30, 2013 | -7.72M |
March 31, 2013 | -9.294M |
December 31, 2012 | -8.316M |
September 30, 2012 | -7.919M |
June 30, 2012 | -8.244M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.793M
Minimum
Mar 2023
1.036M
Maximum
Dec 2019
-2.642M
Average
-2.512M
Median
Cash from Operations (Quarterly) Benchmarks
Perspective Therapeutics Inc | 3.366M |
Retractable Technologies Inc | -5.727M |
InfuSystems Holdings Inc | 9.842M |
Xtant Medical Holdings Inc | -1.718M |
Catheter Precision Inc | -2.768M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.009M |
Free Cash Flow | -11.95M |
Free Cash Flow Per Share (Quarterly) | -0.4702 |
Free Cash Flow Yield | -147.7% |